Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer von McNamara, M.G, Templeton, A.J, Maganti, M, Walter, T, Horgan, A.M, McKeever, L, Min, T, Amir, E, Knox, J.J

Volltext

COVID-19 and its impact on visitation and management at US national parks von Templeton, A.J., Goonan, Kelly, Fyall, Alan

Volltext

Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies von Srikanthan, A, Vera-Badillo, F, Ethier, J, Goldstein, R, Templeton, A.J, Ocana, A, Seruga, B, Amir, E

Volltext

1229 Industry-Sponsored Posters at Major Oncology Conferences: Science or Marketing? von Guerra, R.B, Toloi, D, Tibau, A, Ocana, A, Seruga, B, Vera-Badillo, F, Amir, E, Tannock, I.F, Templeton, A.J

Volltext

Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials von AlHashem, H.Y, Al-Mubarak, M, Vera-Badillo, F.E, Templeton, A.J, Ocana, A, Seruga, B, Amir, E

Volltext

Vitamin D levels in Swiss breast cancer survivors von Baumann, M, Dani, S, Dietrich, D, Hochstrasser, A, Mark, M.T, Riesen, W, Ruhstaller, T, Templeton, A.J, Thürlimann, B

Volltext

1204 Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs von Ethier, J.L, Dýez-González, L, Corrales-Sánchez, V, Srikanthan, A, Gascón-Escribano, M.J, Templeton, A.J, Vera-Badillo, F, Seruga, B, Niraula, S, Pandiella, A, Amir, E, Ocana, A

Volltext

1215 Role of cooperative groups and funding source in clinical studies that support approved therapy for breast cancer von Anguera, G, Tibau, A, Andrés-Pretel, F, Andrés, M, Seruga, B, Templeton, A.J, Jerez, Y, Vera-Badillo, F, Barnadas, A, Martin, M, Amir, E, Ocańa, A

Volltext

2589 Adjuvant radiation therapy after radical nephrectomy in patients with localized renal cell carcinoma: a systematic review and meta-analysis von Badillo, F.E. Vera, Gonzalez-Guerrero, J.F, Rodriguez-Fernandez, I.A, Gonzalez-Conchas, I.A, Verdines-Perez, A, Templeton, A.J, Ocana, A, Seruga, B, Tannock, I.F, Amir, E

Volltext

Flawed trials for cancer von Tannock, I.F., Templeton, A.J.

Volltext

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline... von Lorente, D., Mateo, J., Templeton, A.J., Zafeiriou, Z., Bianchini, D., Ferraldeschi, R., Bahl, A., Shen, L., Su, Z., Sartor, O., de Bono, J.S.

Volltext

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer von Armstrong, A.J., Lin, P., Higano, C.S., Sternberg, C.N., Sonpavde, G., Tombal, B., Templeton, A.J., Fizazi, K., Phung, D., Wong, E.K., Krivoshik, A., Beer, T.M.

Volltext

1704P Clinical benefit of cancer drugs approved by the US food and drug administration based on appropriateness of control arm and its change over time von Molto, C., Restrepo, A.P., Templeton, A.J., Tibau, A., Mittal, A., Tamimi, F.T., Malon Gimenez, D., Amir, E.

Volltext

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized ph... von van Soest, R.J., Templeton, A.J., Vera-Badillo, F.E., Mercier, F., Sonpavde, G., Amir, E., Tombal, B., Rosenthal, M., Eisenberger, M.A., Tannock, I.F., de Wit, R.

Volltext

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical... von Templeton, A.J., Vera-Badillo, F.E., Wang, L., Attalla, M., De Gouveia, P., Leibowitz-Amit, R., Knox, J.J., Moore, M., Sridhar, S.S., Joshua, A.M., Pond, G.R., Amir, E., Tannock, I.F.

Volltext

Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer von Servant, R., Parmentier, R., Dolgos, R., Wang, J., Diamantopoulou, Z., Roma, L., Stenner, F., Templeton, A.J., Aceto, N., Bubendorf, L., Seifert, H., Rentsch, C.A., Le Magnen, C.

Volltext

A0529 - Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer von Servant, R., Parmentier, R., Dolgos, R., Wang, J., Diamantopoulou, Z., Roma, L., Stenner, F., Templeton, A.J., Aceto, N., Bubendorf, L., Seifert, H., Rentsch, C.A., Le Magnen, C.

Volltext

1583O Clinical benefit of cancer drugs approved in Switzerland during the last decade von Adam, R., Tibau, A., Molto Valiente, C., Seruga, B., Ocaña, A., Amir, E., Templeton, A.J.

Volltext

Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer von Roma, L., Bratic Hench, I., Conticelli, F., Bubendorf, L., Calgua, B., Le Magnen, C., Piscuoglio, S., Rubin, M., Chirindel, A., Nicolas, G.P., Vlajnic, T., Zellweger, T., Templeton, A.J., Stenner, F., Ruiz, C., Rentsch, C.

Volltext

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer von Roma, L., Bratic Hench, I., Conticelli, F., Bubendorf, L., Calgua, B., Le Magnen, C., Piscuoglio, S., Rubin, M., Chirindel, A., Nicolas, G.P., Vlajnic, T., Zellweger, T., Templeton, A.J., Stenner, F., Ruiz, C., Rentsch, C.

Volltext